These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18027173)

  • 1. siRNA targeting mammalian target of rapamycin (mTOR) attenuates experimental proliferative vitreoretinopathy.
    Zhou P; Zhao MW; Li XX; Yu WZ; Bian ZM
    Curr Eye Res; 2007 Nov; 32(11):973-84. PubMed ID: 18027173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
    Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
    Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy.
    Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X
    Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
    Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of specific ROCK inhibitor in the prevention of experimental PVR in rabbits].
    Zheng YP; Sun NX; Xiong QC; Quan YL; Wang F
    Zhonghua Yan Ke Za Zhi; 2005 Dec; 41(12):1112-8. PubMed ID: 16409766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
    Ikuno Y; Leong FL; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
    Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
    BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by alkylphosphocholines.
    Eibl KH; Kook D; Priglinger S; Haritoglou C; Yu A; Kampik A; Welge-Lussen U
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):364-70. PubMed ID: 16384986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
    Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration of retinal pigment epithelium cells is regulated by protein kinase Cα in vitro.
    Qiu S; Jiang Z; Huang Z; Chen X; Qian X; Gao Q; Zheng H
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7082-90. PubMed ID: 24084091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo models of proliferative vitreoretinopathy.
    Agrawal RN; He S; Spee C; Cui JZ; Ryan SJ; Hinton DR
    Nat Protoc; 2007; 2(1):67-77. PubMed ID: 17401340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the matricellular protein SPARC on human retinal pigment epithelial cell behavior.
    Hagan S; Hiscott P; Sheridan CM; Wong D; Grierson I; McGalliard J
    Mol Vis; 2003 Mar; 9():87-92. PubMed ID: 12655283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of MEK-ERK1/2 by glutamate receptor-stimulation is involved in the regulation of RPE proliferation and morphologic transformation.
    Pacheco-Domínguez RL; Palma-Nicolas JP; López E; López-Colomé AM
    Exp Eye Res; 2008 Feb; 86(2):207-19. PubMed ID: 18061165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muller cell reactivity and photoreceptor cell death are reduced after experimental retinal detachment using an inhibitor of the Akt/mTOR pathway.
    Lewis GP; Chapin EA; Byun J; Luna G; Sherris D; Fisher SK
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4429-35. PubMed ID: 19369237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine.
    Umazume K; Liu L; Scott PA; de Castro JP; McDonald K; Kaplan HJ; Tamiya S
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1150-9. PubMed ID: 23341014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new model of proliferative vitreoretinopathy.
    Frenzel EM; Neely KA; Walsh AW; Cameron JD; Gregerson DS
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.